Reviewing the Rationale for and Considering Reductions in Cross-Shareholdings
First written in FY2023. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「During the fiscal year, the number of shares held decreased for 1 stock other than non-listed stocks, and the total sales value related to the decrease in shareholdings was ¥691 million.」
The company sold 1 policy-held stock during the fiscal year for total proceeds of ¥691 million. The number of holdings became 14 stocks. - FY2025AdvancedAnnual report
「During the fiscal year, the number of shares held decreased for 2 non-listed stocks and other stocks, and the total sales value related to the decrease in shareholdings was ¥436 million. We will consider selling shares deemed to have limited strategic significance in due course.」
The company sold 2 policy-held stocks for total proceeds of ¥436 million, demonstrating that the review of their rationale and consideration of reducing holdings had led to actual results. - FY2023First statedAnnual report
「Each fiscal year, the Board of Directors examines and determines whether to continue holding each individual stock based on specific figures and evidence, including the purpose of holding all policy-held shares, transaction status during the past year, medium- to long-term economic rationality and future outlook, and dividend amounts.」
For policy-held shares, the company disclosed for the first time that the Board of Directors verifies the holdings each fiscal year based on figures and evidence and considers selling shares with limited strategic significance.